Supplementary Data for Smith et al SPARTAN AR Aberrations from Blood Biomarker Landscape in Patients with High-risk Nonmetastatic Castration-Resistant Prostate Cancer Treated with Apalutamide and Androgen-Deprivation Therapy as They Progress to Metastatic Disease

Supplementary Data for Smith et al SPARTAN AR Aberrations</p

Supplementary Data from Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer

Supplementary materials for Fendler et al.</p